Roney, Miah and Huq, A. K. M. Moyeenul and Mohd Fadhlizil Fasihi, Mohd Aluwi (2024) Concerns regarding SARS-CoV-2 JN.1 mutations should be raised. Bulletin of the National Research Centre, 48 (53). pp. 1-5. ISSN 2522-8307. (Published)
|
Pdf
The importance of in-silico studies in drug discovery.pdf Available under License Creative Commons Attribution. Download (157kB) | Preview |
Abstract
JN.1 is a new variant of SARS-CoV-2 which is a subvariant of Omicron (BA.2.86) was first discovered in the USA in September 2023. The virus’s capacity to spread and elude the immune system may be impacted by a single alteration in the spike protein, which serves as its distinguishing feature. JN.1 has been classified as an interesting variety by the World Health Organisation. JN.1 might lead to a rise in infections, or its possible influence on public health is yet premature. Current immunisations, examinations, and therapies are still anticipated to combat JN.1.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | SARS-CoV-2; SARS-CoV-2 JN.1; mutations; Omicron (BA.2.86); WHO |
| Subjects: | H Social Sciences > HD Industries. Land use. Labor R Medicine > RZ Other systems of medicine |
| Faculty/Division: | Faculty of Industrial Sciences And Technology Institute of Postgraduate Studies Centre for Bioaromatic Research (Bioaromatic Centre) |
| Depositing User: | Miss Amelia Binti Hasan |
| Date Deposited: | 28 Jun 2024 00:50 |
| Last Modified: | 28 Jun 2024 00:50 |
| URI: | http://umpir.ump.edu.my/id/eprint/41715 |
| Download Statistic: | View Download Statistics |
Actions (login required)
 |
View Item |